- Previous Close
10.20 - Open
10.50 - Bid 9.10 x --
- Ask 12.10 x --
- Day's Range
10.50 - 10.50 - 52 Week Range
8.90 - 11.50 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
5.842B - Beta (5Y Monthly) 0.06
- PE Ratio (TTM)
19.09 - EPS (TTM)
0.55 - Earnings Date May 9, 2025
- Forward Dividend & Yield 0.30 (2.95%)
- Ex-Dividend Date Sep 30, 2024
- 1y Target Est
--
Meiji Holdings Co., Ltd., through its subsidiaries, engages in the manufacture and sale of dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, cheese, drinking milk, beverages, butter, margarine, cream, ice cream, frozen food, chocolates, gummy, chewing gums, sports nutrition products, protein, infant formula, enteral formula, beauty supplements, OTC drugs, feed stuffs, sugar, and corn sweeteners. The company also offers ethical pharmaceutical products, including drugs for infectious and CNC disorders, vaccines, blood plasma products, generic drugs, and animal health products. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.
www.meiji.com17,270
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: 3M00.F
View MorePerformance Overview: 3M00.F
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3M00.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3M00.F
View MoreValuation Measures
Market Cap
5.67B
Enterprise Value
5.67B
Trailing P/E
18.42
Forward P/E
15.31
PEG Ratio (5yr expected)
2.16
Price/Sales (ttm)
0.79
Price/Book (mrq)
1.21
Enterprise Value/Revenue
0.80
Enterprise Value/EBITDA
6.70
Financial Highlights
Profitability and Income Statement
Profit Margin
4.30%
Return on Assets (ttm)
4.13%
Return on Equity (ttm)
6.56%
Revenue (ttm)
1.15T
Net Income Avi to Common (ttm)
49.35B
Diluted EPS (ttm)
0.55
Balance Sheet and Cash Flow
Total Cash (mrq)
93.16B
Total Debt/Equity (mrq)
11.69%
Levered Free Cash Flow (ttm)
12.71B